Spermosens recruits first couple for clinical study on next-generation male fertility diagnostic product October 4, 2024
Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11 September 30, 2024
Spermosens next-generation male fertility diagnostic product ready for clinical study September 25, 2024
PCI Pharma Services Invests Over $365 Millionin EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products September 25, 2024
Takeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK-861 on the Burden of Narcolepsy at Sleep Europe 2024 September 22, 2024
